Dietary Oil to Improve Sleep Quality
SNACk
1 other identifier
interventional
16
0 countries
N/A
Brief Summary
The purpose of this study is to identify if healthy cookies high in linoleic acid can change sleep quality and sleep architecture, blood fatty acid composition and be consumed with high compliance after eight weeks of consumption. The hypothesis is that consumption of healthy cookies for 8 weeks will improve sleep quality, increase linoleic acid in the blood and be consumed with greater than 80% compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2027
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 21, 2020
CompletedStudy Start
First participant enrolled
December 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
Study Completion
Last participant's last visit for all outcomes
December 1, 2029
December 9, 2025
December 1, 2025
1 year
September 18, 2020
December 2, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Changes in sleep quality using the Pittsburgh Sleep quality index, PROMIS Sleep questionnaire, and insomnia severity index questionnaire
Changes in global sleep quality scores using the Pittsburgh sleep quality index PROMIS Sleep questionnaire, and insomnia severity index measurements
Week 0, week 4 and week 8
Feasibility of daily healthy cookie consumption
Percent of healthy cookies consumed
Week 8
Changes in blood fatty acids
Changes in linoleic acid levels in the blood
Week 0, week 4 and week 8
Changes in markers of circadian rhythm
Changes in mRNA expression of genes related to circadian rhythm in peripheral blood mononuclear cells
Week 0, week 4 and week 8
Changes in blood lipidomic profiles
Changes in linoleic acid oxylipins in plasma and cardiolipin in peripheral blood mononuclear cells
Week 0, week 4 and week 8
Changes in activity during waking and sleeping hours using an actigraph
Changes in activity during waking and sleeping hours each day will be measured using actigraphy
Week 0, week 4 and week 8
Changes in sleep electroencephalography (EEG)
Changes in sleep EEG will be measured to determine sleep efficiency, arousal index, total sleep time
Week 0, week 4 and week 8
Secondary Outcomes (4)
Changes in body shape using body mass index (calculated using height and weight) and abdominal thickness
Week 0 and week 8
Changes in marker of glycemia
Week 0, week 4 and week 8
Changes in markers of muscle function using gait speed and grip strength
Week 0 and week 8
Changes in markers of inflammation
Week 0, week 4 and week 8
Study Arms (1)
Healthy Cookie Group
EXPERIMENTALAll participants in the study
Interventions
High Linoleic Acid Healthy Cookies (containing about 9g of linoleic acid) 1 per day for 8 weeks
Eligibility Criteria
You may qualify if:
- Overweight (BMI ≥25 and \<38)
- Nonsmoker
- Insomnia severity index score ≥8
You may not qualify if:
- Current or previous diagnosis of diabetes, heart (including stroke or heart attack), kidney, liver or circulatory diseases and/or current treatment for cancer
- Gastrointestinal diseases or disorders (including pancreatic) or gastric bypass surgery
- Food Allergy or Intolerance
- Any dietary restriction where consumption of these healthy cookies or any ingredient would be contraindicated
- Use of medications where consuming the healthy cookies would be contraindicated
- Usage of sleep aid (prescription medication(s)) for insomnia
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 18, 2020
First Posted
December 21, 2020
Study Start (Estimated)
December 1, 2027
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2029
Last Updated
December 9, 2025
Record last verified: 2025-12